1 / 3
google
Details
- GTIN
- 7680692660015
- Pharmacode
- -
- Product number
- 6926601
- CPT
- -
- Packaging group
- 20
- Unit
- Tablette(n)
- Composition
- paracetamolum 500 mg, hypromellosum, povidonum K 90, carmellosum natricum conexum corresp. natrium 2.07 mg, cellulosum microcristallinum, glyceroli dibehenas, magnesii stearas, pro compresso.
Articles (1)
Dafalgan 500 mg, Tabletten
Tabletten
20
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
paracetamolum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosum
|
- | Substance | HNIDK |
|
povidonum K 90
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
2.07 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
glyceroli dibehenas
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69266
- Drug name
- Dafalgan, Tabletten
- Galenic form
- TAB
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/03/2024
- Authorization expiration date
- 27/03/2029
- IT number
- 01.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAFALGAN cpr 500 mg 20 pce
- Description (DE)
- DAFALGAN Tabl 500 mg 20 Stk
- Market launch
- 01/03/2026
- Narcotic (BTM)
- No